Here we highlight publications from SSMB members.
Walser, M. et. al., 2017. β-Integrin de-phosphorylation by the Density-Enhanced Phosphatase DEP-1 attenuates EGFR signaling in C. elegans. PLoS Genet. 2017 Jan 30;13(1):e1006592. doi: 10.1371/journal.pgen.1006592. eCollection 2017.
A cohort of 17 patients with kyphoscoliotic Ehlers-Danlos syndrome caused by biallelic mutations in FKBP14: expansion of the clinical and mutational spectrum and description of the natural history.
GENETICS in MEDICINE 2017; DOI: 10.1038/gim.2017.70
Lukjanenko, L. et al., 2016. Loss of fibronectin from the aged stem cell niche affects the regenerative capacity of skeletal muscle in mice. Nature medicine, pp.1–11.
Burkhardt, M.A. et al., 2016. Synergistic interactions of blood-borne immune cells, fibroblasts and extracellular matrix drive repair in an in vitro peri-implant wound healing model. Scientific reports, 6, p.21071.
MBTPS2 mutations cause defective regulated intramembrane proteolysis in X-linked osteogenesis imperfecta.
Nature Communications 2016; DOI: 10.1038/ncomms11920
Grandl, G. et al., 2016. Depot specific differences in the adipogenic potential of precursors are mediated by collagenous extracellular matrix and Flotillin 2 dependent signaling. Mol Metab. 5, 937-47. doi: 10.1016/j.molmet.2016.07.008
Ewald, C.Y. et al., 2015. Dauer-independent insulin/IGF-1-signalling implicates collagen remodelling in longevity. Nature, 519(7541), pp.97–101.
Molecular consequences of the SERPINH1/HSP47 mutation in the dachshund natural model of osteogenesis imperfecta.
Journal of Biological Chemistry 2015; DOI: 10.1074/jbc.M115.661025
Yalak, G. & Vogel, V., 2015. Ectokinases as novel cancer markers and drug targets in cancer therapy. Cancer medicine, 4(3), pp.404–414.